References
- Cardiovascular diseases(CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
- Noh JW, Jeong SM, Kim DH, Yoo JH, Ahn YM, Ahn SY, et al. A Retrospective Study on the Effect of Daeshiho-tang on the Lipid Profile in Patients with Uncontrolled Dyslipidemia by Statins. J Int Korean Med 2019;40(6):1026-34. https://doi.org/10.22246/jikm.2019.40.6.1026
- The Korean Society of Lipid and Atherosclerosis (KSoLA) Committee of Clinical Practice Guideline. Korean Guidelines for the Management of Dyslipidemia(the 5th edition). Seoul: The Korean Society of Lipid and Atherosclerosis; 2022, p. 19, 31-3, 45, 84, 94-125.
- Ryu JY, Cho HK, Yoo HR, Seol IC, Kim YS. The Effects of Artemisiae Iwayomogii Herba, Curcumae Radix, and Aurantii Fructus Immaturus Complex Extract (ACA) on Dyslipidemia-related Factor Expression and Anti-oxidation in HepG2 Cells. J Int Korean Med 2017;38(3):367-75. https://doi.org/10.22246/jikm.2017.38.3.367
- Kim KS, Cha MH, Lee SW, Yoon YS. A Study on the Inhibitory Effects of Scutellariae Radix on Fat Accumulation. Korean Journal of Oriental Medicine 2003;9(2):45-54.
- An GY, Jo JJ, Shin MG, Jeon SY. Study of the effects of gugijagami-bang in a hyperlipidemic animal model induced with a high-fat diet. J Int Korean Med 2014;35(4):505-18.
- Bang HJ, Tak ES, Hong Y, Kang YH. A Study on The Oriental-medical Understanding of Hyperlipidemia. The Journal of east-west medicines 1995;20(1):25-36.
- 張仲景. 金匱要略心典 譯解. Seoul: Jipmoondang; 2008, p. 214-6.
- Lee KJ, Ji NK, Cho KH. A case of dizziness patient suggested Benign Positional Vertigo treated by Zexictang. J Int Korean Med 1999;20(2):705-10.
- Na HY, Lee SW, Yoo JH, Ahn SY, Lee BC, Ahn YM. A Case Report of Vertigo Patient with Vestibulopathy Improved with Zexie-tang. J Int Korean Med 2015;fal:123-8.
- Lee YJ, Lee EB, Kim HJ, Yang DH, Kim YJ, An HD. The Effects of Taeksa-tang on Blood Lipid Profile and Anti Oxidation. J Korean Med Rehabil 2021;31(2):1-14. https://doi.org/10.18325/jkmr.2021.31.2.1
- Nam SK, Lee DS, Kim NJ, Lee KS, Hong ND. Studies on the Efficacy of Combined Preparation of Crude Drugs(XXXI) - The Effect of Taeksa -tang on Diuresis, Serum Lipid, Isolated Ileum, Heart, Blood Vessel, Blood Pressure and Respiration. Korean Journal of Pharmacognosy 1986;17(4):263-71.
- Hong YK, Kim SS, Shin MK, Kim JJ. Review of Korean Medical Treatment in Hyperlipidemia - Focusing on Treatment of Korean Herbal Medicine. Korean J Oriental Physiology & Pathology 2010;24(1):9-14.
- Kim SY, Park JE, Seo HJ, Lee YJ, Jang BH, Son HJ, et al. NECA's Guidance for Undertaking Systematic Reviews and Meta-analyses for Intervention. Seoul: National Evidence-based Health care Collaborating Agency; 2011, p. 1-287.
- Lee JY. Meta-anallysis. J Korean Endocrinolog 2008;23(6):361-78. https://doi.org/10.3803/jkes.2008.23.6.361
- 顾国龙, 刘峥. 泽泻汤治疗高血压病合并高脂血症. 湖北中医杂志 2003;25(4):9-10.
- 展照双, 王加锋. 茯苓泽泻汤加味治疗高脂蛋白血 症49例. 北京中医 2004;23(1):24-6.
- 崔德成, 崔丽平. 自拟泽泻柴胡汤治疗高脂血症的 临床观察. 北京中医 2004;23(3):152-3.
- 赵坤元. "首乌泽泻汤" 治疗高脂血症60例临床观察. 江苏中医药 2006;27(5):32-3.
- 秦泗关, 张有涛, 吴晓青, 郝立鹏, 阳其娟. 大黄茯苓泽泻汤治疗2型糖尿病合并高脂血症临床观察. CJCM 2012;4(18):80-1.
- 高源. 泽泻汤在高脂血症治疗中的应用效果观察. 世界最新医学信息文摘 2016;16(61):239-41.
- 何杰先. 泽泻汤治疗高脂血症的临床疗效观察. 双足与保健 2017;26(12):178-9.
- 李爱珍. 泽泻汤治疗高脂血症的临床疗效. 临床合理用药杂志 2018;11(36):114-5.
- 李白云. 大黃蟅虫丸合泽泻汤加减治疗高脂血症60例临床观察. 哈尔滨医药 2019;39(2):187-8. https://doi.org/10.26549/yzlcyxzz.v2i5.2668
- Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999;69(2):231-6. https://doi.org/10.1093/ajcn/69.2.231
- Liang L, Shao W, Shu T, Zhang Y, Xu S, Guo L, et al. Xuezhikang improves the outcomes of cardiopulmonary resuscitation in rats by suppressing the inflammation response through TLR4/NF-κB pathway. Biomed Pharmacother 2019;114:108817.
- Xu G, Lin M, Dai X, Hu J. Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta-analysis of randomized controlled trials. Endocrinol Diabetes Metab 2022;5(1):e00314.
- Hao SY, Wang L, Li H, Zhang D, Xu H. Simultaneous determination of lovastatin and lovastatin acid in fermentum Rubrum and Zhibituo tablets by QAMS. Chin J Exp Trad Med Formulae 2017;23:74-8.
- Khorshidi M, Zarezadeh M, Moradi Moghaddam O, Emami MR, Kord-Varkaneh H, Mousavi SM, et al. Effect of evening primrose oil supplementation on lipid profile: A systematic review and meta-analysis of randomized clinical trials. Phytother Res 2020;34(10):2628-38. https://doi.org/10.1002/ptr.6716
- Statistics Korea. 2021 Death statistics. Daejeon: Statistics Korea; 2021. p. 6.
- Arafa A, Lee HH, Eshak ES, Shirai K, Liu K, Li J, et al. Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan. Korean Circ J 2021;51(8):643-55. https://doi.org/10.4070/kcj.2021.0121
- Korea Disease Control and Prevenion Agency. 2020 Chronic Disease Status and Issues - Chronic Disease Factbook. Cheongju: Korea Disease Control and Prevenion Agency; 2020, p. 17-74.
- Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long-term statin therapy? Current Atherosclerosis Reports 2013;15(1):291.
- Lee SR, Ock MY, Kim HA. Comparison of Adverse Events between High-intensity and Moderate- to Low-intensity Statin Group. Korean J Clin Pharm 2018;28(4):293-9. https://doi.org/10.24304/kjcp.2018.28.4.293
- Yang YG. The translation of Hwangjenaegyung. 1st edition. Seoul: Iljoongsa; 1991, p. 296-7, 416.
- Heo J. Donguibogam. Seoul: Namsandang; 1975, p. 128, 202.
- College of Oriental Medicine Herbology Compilation Committee. Herbology. 2nd edition. Seoul: Yeongrimsa; 2010, p. 348-9, 579-80.